Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis
- PMID: 36800114
- DOI: 10.1007/s12640-022-00632-1
Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal illness characterized by progressive motor neuron degeneration. Conventional therapies for ALS are based on treatment of symptoms, and the disease remains incurable. Molecular mechanisms are unclear, but studies have been pointing to involvement of glia, neuroinflammation, oxidative stress, and glutamate excitotoxicity as a key factor. Nowadays, we have few treatments for this disease that only delays death, but also does not stop the neurodegenerative process. These treatments are based on glutamate blockage (riluzole), tyrosine kinase inhibition (masitinib), and antioxidant activity (edaravone). In the past few years, plant-derived compounds have been studied for neurodegenerative disorder therapies based on neuroprotection and glial cell response. In this review, we describe mechanisms of action of natural compounds associated with neuroprotective effects, and the possibilities for new therapeutic strategies in ALS.
Keywords: Amyotrophic lateral sclerosis; Glial cells; Motor neurons; Natural compounds; Neuroprotection.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Amyotrophic Lateral Sclerosis: Pathophysiological Mechanisms and Treatment Strategies (Part 2).Int J Mol Sci. 2025 May 29;26(11):5240. doi: 10.3390/ijms26115240. Int J Mol Sci. 2025. PMID: 40508048 Free PMC article. Review.
-
Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis.Int J Mol Sci. 2022 Feb 22;23(5):2400. doi: 10.3390/ijms23052400. Int J Mol Sci. 2022. PMID: 35269543 Free PMC article. Review.
-
Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series.Biomed Pharmacother. 2023 Apr;160:114378. doi: 10.1016/j.biopha.2023.114378. Epub 2023 Feb 10. Biomed Pharmacother. 2023. PMID: 36774721 Review.
-
Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs.Med Res Rev. 2019 Mar;39(2):733-748. doi: 10.1002/med.21528. Epub 2018 Aug 12. Med Res Rev. 2019. PMID: 30101496 Review.
-
Edaravone for the treatment of amyotrophic lateral sclerosis.Expert Rev Neurother. 2019 Mar;19(3):185-193. doi: 10.1080/14737175.2019.1581610. Epub 2019 Feb 27. Expert Rev Neurother. 2019. PMID: 30810406 Review.
Cited by
-
Evaluation of the Possible Pathways Involved in the Protective Effects of Quercetin, Naringenin, and Rutin at the Gene, Protein and miRNA Levels Using In-Silico Multidimensional Data Analysis.Molecules. 2023 Jun 21;28(13):4904. doi: 10.3390/molecules28134904. Molecules. 2023. PMID: 37446564 Free PMC article.
-
An Overview of the Synthesis of 3,4-Fused Pyrrolocoumarins of Biological Interest.Molecules. 2024 Jun 9;29(12):2748. doi: 10.3390/molecules29122748. Molecules. 2024. PMID: 38930816 Free PMC article. Review.
-
Dichloromethane Extract from Amburana cearensis (Allemão) A.C. Sm. Seeds and Its Coumarin Reduce ROS Production and Protect PC12 Cells Against Glutamate Excitotoxicity and Oxygen-Glucose Deprivation.Antioxidants (Basel). 2025 Apr 5;14(4):440. doi: 10.3390/antiox14040440. Antioxidants (Basel). 2025. PMID: 40298820 Free PMC article.
-
Computational study of the motor neuron protein KIF5A to identify nsSNPs, bioactive compounds, and its key regulators.Front Genet. 2023 Nov 10;14:1282234. doi: 10.3389/fgene.2023.1282234. eCollection 2023. Front Genet. 2023. PMID: 38028604 Free PMC article.
-
An Overview on the Synthesis of Lamellarins and Related Compounds with Biological Interest.Molecules. 2024 Aug 26;29(17):4032. doi: 10.3390/molecules29174032. Molecules. 2024. PMID: 39274880 Free PMC article. Review.
References
-
- Abrahams S, Haylett WL, Johnson G, Carr JA, Bardien S (2019) Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: a review. Neuroscience 406:1–21. https://doi.org/10.1016/j.neuroscience.2019.02.020 - DOI - PubMed
-
- Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 9(11):617–628. https://doi.org/10.1038/nrneurol.2013.203 - DOI - PubMed
-
- Allaman I, Bélanger M, Magistretti PJ (2011) Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci 34(2):76–87. https://doi.org/10.1016/j.tins.2010.12.001 - DOI - PubMed
-
- Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61(5):435–445. https://doi.org/10.1002/ana.21154 - DOI - PubMed - PMC
-
- Anneser JM, Cookson MR, Ince PG, Shaw PJ, Borasio GD (2001) Glial cells of the spinal cord and subcortical white matter upregulate neuronal nitric oxide synthase in sporadic amyotrophic lateral sclerosis. Exp Neurol 171(2):418–421. https://doi.org/10.1006/exnr.2001.7756 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous